SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2nnj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OG5_A_SWFA502_1
(CYTOCHROME P450 2C9)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 ARG A  97
LEU A 208
ASN A 217
THR A 364
PRO A 367
HEM  A 500 (-2.6A)
225  A 501 ( 4.3A)
None
None
225  A 501 ( 4.7A)
0.92A 1og5A-2nnjA:
55.0
1og5A-2nnjA:
78.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1R9O_A_FLPA501_1
(CYTOCHROME P450 2C9)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
6 / 12 ASN A 204
LEU A 208
VAL A 237
ASP A 293
ALA A 297
THR A 301
None
225  A 501 ( 4.3A)
None
None
HEM  A 500 (-3.5A)
HEM  A 500 ( 3.7A)
0.55A 1r9oA-2nnjA:
54.0
1r9oA-2nnjA:
78.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1V8B_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
3 / 3 GLU A  85
GLU A  93
LEU A 380
None
0.68A 1v8bA-2nnjA:
undetectable
1v8bA-2nnjA:
21.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BDM_A_TMIA501_1
(CYTOCHROME P450 2B4)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 7 LEU A 294
PHE A 295
GLY A 298
THR A 302
HEM  A 500 ( 4.3A)
None
HEM  A 500 (-3.4A)
HEM  A 500 (-4.2A)
0.49A 2bdmA-2nnjA:
39.7
2bdmA-2nnjA:
55.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BFP_C_H4BC1290_1
(PTERIDINE REDUCTASE
1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 8 PHE A 487
LEU A 170
LEU A 449
LEU A 313
None
0.98A 2bfpC-2nnjA:
undetectable
2bfpC-2nnjA:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2M9Q_B_BEZB251_0
(SERINE PROTEASE
INHIBITOR
SERINE PROTEASE
SUBUNIT NS2B, SERINE
PROTEASE NS3)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 9 LEU A 128
PHE A 263
THR A 290
ALA A 436
LEU A 131
None
None
None
HEM  A 500 (-3.7A)
HEM  A 500 ( 4.9A)
1.17A 2m9qA-2nnjA:
undetectable
2m9qA-2nnjA:
19.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_A_9CRA501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
9 / 11 ARG A  97
SER A 100
ILE A 113
SER A 114
ALA A 297
THR A 301
VAL A 366
PRO A 367
ILE A 476
HEM  A 500 (-2.6A)
None
225  A 501 ( 4.3A)
None
HEM  A 500 (-3.5A)
HEM  A 500 ( 3.7A)
225  A 501 ( 3.7A)
225  A 501 ( 4.7A)
225  A 501 ( 3.9A)
0.70A 2nnhA-2nnjA:
62.3
2nnhA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_A_9CRA501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
9 / 11 ARG A  97
SER A 100
SER A 103
ILE A 113
SER A 114
ALA A 297
THR A 301
VAL A 366
PRO A 367
HEM  A 500 (-2.6A)
None
225  A 501 ( 4.0A)
225  A 501 ( 4.3A)
None
HEM  A 500 (-3.5A)
HEM  A 500 ( 3.7A)
225  A 501 ( 3.7A)
225  A 501 ( 4.7A)
0.61A 2nnhA-2nnjA:
62.3
2nnhA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_A_9CRA501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
6 / 11 GLY A  98
SER A 100
ILE A 113
SER A 114
ALA A 297
ILE A 476
None
None
225  A 501 ( 4.3A)
None
HEM  A 500 (-3.5A)
225  A 501 ( 3.9A)
0.91A 2nnhA-2nnjA:
62.3
2nnhA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_A_9CRA501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
6 / 11 GLY A  98
SER A 100
SER A 103
ILE A 113
SER A 114
ALA A 297
None
None
225  A 501 ( 4.0A)
225  A 501 ( 4.3A)
None
HEM  A 500 (-3.5A)
0.89A 2nnhA-2nnjA:
62.3
2nnhA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_A_9CRA502_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
6 / 12 SER A 100
ASN A 209
ASN A 217
VAL A 237
VAL A 296
ILE A 476
None
None
None
None
None
225  A 501 ( 3.9A)
0.68A 2nnhA-2nnjA:
62.3
2nnhA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_A_9CRA502_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
9 / 12 SER A 100
ILE A 102
ILE A 106
ASN A 204
LEU A 208
ASN A 209
ASN A 217
VAL A 237
VAL A 296
None
PLM  A 502 ( 4.1A)
PLM  A 502 (-4.6A)
None
225  A 501 ( 4.3A)
None
None
None
None
0.59A 2nnhA-2nnjA:
62.3
2nnhA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_A_9CRA502_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
9 / 12 SER A 100
ILE A 102
SER A 103
ILE A 106
ASN A 204
ASN A 209
ASN A 217
VAL A 237
VAL A 296
None
PLM  A 502 ( 4.1A)
225  A 501 ( 4.0A)
PLM  A 502 (-4.6A)
None
None
None
None
None
0.64A 2nnhA-2nnjA:
62.3
2nnhA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_A_9CRA502_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
7 / 12 SER A 100
ILE A 102
SER A 103
ILE A 106
ASN A 217
VAL A 237
ARG A 241
None
PLM  A 502 ( 4.1A)
225  A 501 ( 4.0A)
PLM  A 502 (-4.6A)
None
None
None
1.49A 2nnhA-2nnjA:
62.3
2nnhA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_B_9CRB501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
7 / 9 ARG A  97
GLY A  98
SER A 100
ILE A 113
THR A 301
ILE A 476
VAL A 477
HEM  A 500 (-2.6A)
None
None
225  A 501 ( 4.3A)
HEM  A 500 ( 3.7A)
225  A 501 ( 3.9A)
None
0.93A 2nnhB-2nnjA:
61.9
2nnhB-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_B_9CRB501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
8 / 9 ARG A  97
SER A 100
ILE A 113
THR A 301
VAL A 366
PRO A 367
ILE A 476
VAL A 477
HEM  A 500 (-2.6A)
None
225  A 501 ( 4.3A)
HEM  A 500 ( 3.7A)
225  A 501 ( 3.7A)
225  A 501 ( 4.7A)
225  A 501 ( 3.9A)
None
0.67A 2nnhB-2nnjA:
61.9
2nnhB-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_B_9CRB501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
6 / 9 ARG A  97
SER A 103
VAL A 366
PRO A 367
ILE A 476
VAL A 477
HEM  A 500 (-2.6A)
225  A 501 ( 4.0A)
225  A 501 ( 3.7A)
225  A 501 ( 4.7A)
225  A 501 ( 3.9A)
None
1.12A 2nnhB-2nnjA:
61.9
2nnhB-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_B_9CRB502_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
7 / 10 SER A 100
ILE A 102
ASN A 204
ASN A 209
ASN A 217
VAL A 296
ILE A 476
None
PLM  A 502 ( 4.1A)
None
None
None
None
225  A 501 ( 3.9A)
0.64A 2nnhB-2nnjA:
61.9
2nnhB-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNH_B_9CRB502_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
8 / 10 SER A 100
ILE A 102
ILE A 106
ASN A 204
LEU A 208
ASN A 209
ASN A 217
VAL A 296
None
PLM  A 502 ( 4.1A)
PLM  A 502 (-4.6A)
None
225  A 501 ( 4.3A)
None
None
None
0.60A 2nnhB-2nnjA:
61.9
2nnhB-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNI_A_MTKA501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 SER A 100
SER A 103
SER A 114
ASN A 217
ALA A 292
None
225  A 501 ( 4.0A)
None
None
None
1.31A 2nniA-2nnjA:
63.1
2nniA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNI_A_MTKA501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
12 / 12 SER A 100
SER A 103
THR A 107
SER A 114
ASN A 204
ASN A 217
THR A 240
VAL A 296
ALA A 297
THR A 301
VAL A 366
VAL A 477
None
225  A 501 ( 4.0A)
None
None
None
None
None
None
HEM  A 500 (-3.5A)
HEM  A 500 ( 3.7A)
225  A 501 ( 3.7A)
None
0.40A 2nniA-2nnjA:
63.1
2nniA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNI_A_MTKA501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
9 / 12 SER A 100
SER A 103
THR A 107
SER A 114
ASN A 217
VAL A 296
ALA A 297
THR A 301
VAL A 362
None
225  A 501 ( 4.0A)
None
None
None
None
HEM  A 500 (-3.5A)
HEM  A 500 ( 3.7A)
HEM  A 500 ( 4.9A)
1.45A 2nniA-2nnjA:
63.1
2nniA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNI_A_MTKA501_2
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
8 / 8 ILE A 102
ILE A 106
ILE A 113
ARG A 200
ILE A 213
ASN A 236
VAL A 237
ALA A 292
PLM  A 502 ( 4.1A)
PLM  A 502 (-4.6A)
225  A 501 ( 4.3A)
None
None
None
None
None
0.66A 2nniA-2nnjA:
63.1
2nniA-2nnjA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
11 / 12 ILE A 106
THR A 107
ASN A 204
PHE A 205
LEU A 208
ASN A 209
VAL A 237
VAL A 296
GLU A 300
THR A 301
ILE A 476
PLM  A 502 (-4.6A)
None
None
None
225  A 501 ( 4.3A)
None
None
None
None
HEM  A 500 ( 3.7A)
225  A 501 ( 3.9A)
0.60A 2vn0A-2nnjA:
63.3
2vn0A-2nnjA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XRH_A_NIOA200_1
(PROTEIN HP0721)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 7 GLY A 437
ILE A 112
THR A 290
LEU A 131
HEM  A 500 ( 3.7A)
HEM  A 500 (-4.1A)
None
HEM  A 500 ( 4.9A)
0.94A 2xrhA-2nnjA:
undetectable
2xrhA-2nnjA:
12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XRZ_B_ACTB1463_0
(DEOXYRIBODIPYRIMIDIN
E PHOTOLYASE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 7 VAL A 370
ILE A 381
GLY A 384
THR A 385
None
0.75A 2xrzB-2nnjA:
undetectable
2xrzB-2nnjA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZM7_A_ACAA501_1
(6-AMINOHEXANOATE-DIM
ER HYDROLASE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 7 ALA A 436
TRP A 120
ILE A 434
HIS A 368
HEM  A 500 (-3.7A)
HEM  A 500 (-4.0A)
None
HEM  A 500 (-3.8A)
1.10A 2zm7A-2nnjA:
undetectable
2zm7A-2nnjA:
21.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E4E_A_4PZA501_1
(CYTOCHROME P450 2E1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
3 / 3 ALA A 297
THR A 301
CYH A 435
HEM  A 500 (-3.5A)
HEM  A 500 ( 3.7A)
HEM  A 500 (-2.3A)
0.52A 3e4eA-2nnjA:
52.3
3e4eA-2nnjA:
59.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3E4E_B_4PZB501_1
(CYTOCHROME P450 2E1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
3 / 3 ALA A 297
THR A 301
CYH A 435
HEM  A 500 (-3.5A)
HEM  A 500 ( 3.7A)
HEM  A 500 (-2.3A)
0.46A 3e4eB-2nnjA:
52.5
3e4eB-2nnjA:
59.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELZ_B_CHDB153_0
(ILEAL BILE
ACID-BINDING PROTEIN)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 6 ILE A 213
THR A 364
PHE A  54
PHE A  69
None
1.17A 3elzB-2nnjA:
undetectable
3elzB-2nnjA:
13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HS4_A_AZMA702_1
(CARBONIC ANHYDRASE 2)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 7 VAL A 323
LYS A 322
TYR A 347
GLU A 354
PRO A 409
None
1.17A 3hs4A-2nnjA:
undetectable
3hs4A-2nnjA:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KM6_B_EAAB222_1
(GLUTATHIONE
S-TRANSFERASE P)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 9 PHE A 226
TRP A 212
VAL A 233
ASN A 231
GLY A 228
PLM  A 502 (-3.9A)
None
None
None
None
1.21A 3km6B-2nnjA:
undetectable
3km6B-2nnjA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU4_B_478B401_2
(PROTEASE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 9 ALA A 436
ILE A 113
GLY A 298
ILE A 178
ILE A 112
HEM  A 500 (-3.7A)
225  A 501 ( 4.3A)
HEM  A 500 (-3.4A)
None
HEM  A 500 (-4.1A)
0.87A 3nu4B-2nnjA:
undetectable
3nu4B-2nnjA:
13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S8P_A_SAMA500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 TYR A  80
GLY A  79
ALA A  82
SER A 429
GLU A 400
None
None
None
HEM  A 500 (-2.9A)
None
1.45A 3s8pA-2nnjA:
undetectable
3s8pA-2nnjA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S8P_B_SAMB500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 TYR A  80
GLY A  79
ALA A  82
SER A 429
GLU A 400
None
None
None
HEM  A 500 (-2.9A)
None
1.42A 3s8pB-2nnjA:
2.2
3s8pB-2nnjA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BUP_A_SAMA500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 TYR A  80
GLY A  79
ALA A  82
SER A 429
GLU A 400
None
None
None
HEM  A 500 (-2.9A)
None
1.43A 4bupA-2nnjA:
undetectable
4bupA-2nnjA:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BUP_B_SAMB500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 TYR A  80
GLY A  79
ALA A  82
SER A 429
GLU A 400
None
None
None
HEM  A 500 (-2.9A)
None
1.41A 4bupB-2nnjA:
1.5
4bupB-2nnjA:
21.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JLT_A_8PRA505_1
(CYTOCHROME P450 2B4)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 8 ILE A 113
ALA A 297
VAL A 366
PRO A 367
225  A 501 ( 4.3A)
HEM  A 500 (-3.5A)
225  A 501 ( 3.7A)
225  A 501 ( 4.7A)
0.25A 4jltA-2nnjA:
54.2
4jltA-2nnjA:
55.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OQR_A_2UOA502_1
(CYP105AS1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 9 VAL A  83
VAL A 370
ALA A 369
THR A 386
ALA A 389
None
1.18A 4oqrA-2nnjA:
30.9
4oqrA-2nnjA:
24.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R38_B_RBFB201_2
(BLUE-LIGHT-ACTIVATED
HISTIDINE KINASE 2)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 8 ILE A 488
LEU A 449
VAL A 153
LEU A 156
None
0.82A 4r38B-2nnjA:
undetectable
4r38B-2nnjA:
14.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4F_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 4 VAL A 296
ALA A 292
PHE A 201
THR A 240
None
1.36A 4z4fA-2nnjA:
undetectable
4z4fA-2nnjA:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4H_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 4 VAL A 296
ALA A 292
PHE A 201
THR A 240
None
1.34A 4z4hA-2nnjA:
0.0
4z4hA-2nnjA:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CPR_B_SAMB402_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 TYR A  80
GLY A  79
ALA A  82
SER A 429
GLU A 400
None
None
None
HEM  A 500 (-2.9A)
None
1.41A 5cprB-2nnjA:
undetectable
5cprB-2nnjA:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E5J_A_017A201_1
(PROTEASE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 ALA A 436
ILE A 113
GLY A 298
ILE A 178
ILE A 112
HEM  A 500 (-3.7A)
225  A 501 ( 4.3A)
HEM  A 500 (-3.4A)
None
HEM  A 500 (-4.1A)
0.83A 5e5jA-2nnjA:
undetectable
5e5jA-2nnjA:
13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E5J_A_017A201_2
(PROTEASE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 ALA A 436
ILE A 113
GLY A 298
ILE A 178
ILE A 112
HEM  A 500 (-3.7A)
225  A 501 ( 4.3A)
HEM  A 500 (-3.4A)
None
HEM  A 500 (-4.1A)
0.88A 5e5jB-2nnjA:
undetectable
5e5jB-2nnjA:
13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HKG_A_RAPA201_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1B)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 PHE A  54
VAL A  67
PHE A  65
VAL A 370
ILE A 381
None
1.19A 5hkgA-2nnjA:
undetectable
5hkgA-2nnjA:
14.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IK1_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 7 THR A 301
VAL A 362
ILE A 476
VAL A 477
HEM  A 500 ( 3.7A)
HEM  A 500 ( 4.9A)
225  A 501 ( 3.9A)
None
0.71A 5ik1A-2nnjA:
30.1
5ik1A-2nnjA:
25.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JGL_B_SAMB301_1
(UBIE/COQ5 FAMILY
METHYLTRANSFERASE,
PUTATIVE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
3 / 3 ASP A 360
ASN A 405
PHE A  54
None
0.86A 5jglB-2nnjA:
undetectable
5jglB-2nnjA:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5T8H_B_478B401_2
(PROTEASE)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 ALA A 436
ILE A 113
GLY A 298
ILE A 178
ILE A 112
HEM  A 500 (-3.7A)
225  A 501 ( 4.3A)
HEM  A 500 (-3.4A)
None
HEM  A 500 (-4.1A)
0.89A 5t8hB-2nnjA:
undetectable
5t8hB-2nnjA:
13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_A_PCFA1805_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 7 PHE A 446
VAL A 352
ILE A 452
THR A 348
None
0.78A 5vkqA-2nnjA:
undetectable
5vkqD-2nnjA:
undetectable
5vkqA-2nnjA:
14.39
5vkqD-2nnjA:
14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WBV_A_SAMA402_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
KMT5B)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 TYR A  80
GLY A  79
ALA A  82
SER A 429
GLU A 400
None
None
None
HEM  A 500 (-2.9A)
None
1.47A 5wbvA-2nnjA:
undetectable
5wbvA-2nnjA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WBV_B_SAMB402_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
KMT5B)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 TYR A  80
GLY A  79
ALA A  82
SER A 429
GLU A 400
None
None
None
HEM  A 500 (-2.9A)
None
1.47A 5wbvB-2nnjA:
undetectable
5wbvB-2nnjA:
20.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5X23_A_LSNA503_1
(CYTOCHROME P450 2C9)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 5 GLY A 228
THR A 229
ASN A 231
LYS A 232
None
PLM  A 502 (-3.9A)
None
None
0.78A 5x23A-2nnjA:
58.2
5x23A-2nnjA:
78.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5X23_A_LSNA503_1
(CYTOCHROME P450 2C9)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 5 PRO A 227
GLY A 228
THR A 229
LYS A 232
None
None
PLM  A 502 (-3.9A)
None
0.43A 5x23A-2nnjA:
58.2
5x23A-2nnjA:
78.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5X23_A_LSNA504_1
(CYTOCHROME P450 2C9)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 8 ILE A  74
ASN A 217
PRO A 363
THR A 364
PRO A 367
None
None
None
None
225  A 501 ( 4.7A)
0.58A 5x23A-2nnjA:
58.2
5x23A-2nnjA:
78.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5X24_A_LSNA503_1
(CYTOCHROME P450 2C9)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
6 / 6 PHE A 226
PRO A 227
GLY A 228
THR A 229
ASN A 231
LYS A 232
PLM  A 502 (-3.9A)
None
None
PLM  A 502 (-3.9A)
None
None
0.74A 5x24A-2nnjA:
57.6
5x24A-2nnjA:
78.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDH_D_DAHD60_1
(PUTATIVE CYTOCHROME
C)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 5 HIS A 368
MET A 426
VAL A 362
LEU A 391
HEM  A 500 (-3.8A)
None
HEM  A 500 ( 4.9A)
None
1.35A 5xdhD-2nnjA:
0.0
5xdhD-2nnjA:
11.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5XXI_A_LSNA502_1
(CYTOCHROME P450 2C9)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
6 / 6 PRO A 227
GLY A 228
THR A 229
ASN A 231
LYS A 232
LYS A 235
None
None
PLM  A 502 (-3.9A)
None
None
None
0.59A 5xxiA-2nnjA:
58.3
5xxiA-2nnjA:
78.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5XXI_A_LSNA503_1
(CYTOCHROME P450 2C9)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
5 / 12 ILE A  74
ASN A 217
PRO A 363
THR A 364
PRO A 367
None
None
None
None
225  A 501 ( 4.7A)
0.54A 5xxiA-2nnjA:
58.3
5xxiA-2nnjA:
78.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YWM_X_NIOX403_0
(CASEIN KINASE II
SUBUNIT ALPHA')
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 7 VAL A  76
VAL A  67
ILE A  45
ILE A  50
None
0.77A 5ywmX-2nnjA:
undetectable
5ywmX-2nnjA:
9.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MN4_F_AM2F301_0
(AMINOGLYCOSIDE
N(3)-ACETYLTRANSFERA
SE, AAC(3)-IVA)
2nnj CYTOCHROME P450 2C8
(Homo
sapiens)
4 / 7 HIS A 329
ARG A 333
HIS A 334
ASP A 328
None
None
SO4  A 503 (-4.0A)
None
1.23A 6mn4F-2nnjA:
undetectable
6mn4F-2nnjA:
18.97